About Clinical Design
Clinical Design is a company based in Truro (United Kingdom) founded in 2014 by Oliver Blackwell.. Clinical Design has raised $7.03 million across 9 funding rounds from investors including Cornwall & Isles of Scilly Investment Fund. The company has 5 employees as of July 31, 2021. Clinical Design offers products and services including UTS, UTS-10 Cap, and UTS Digital Analyser. Clinical Design operates in a competitive market with competitors including Bright Uro, DNC Biotechnology, Stream DX, COBIO Smart Healthcare Technology and Clariflow, among others.
- Headquarter Truro, United Kingdom
- Employees 5 as on 31 Jul, 2021
- Founders Oliver Blackwell
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Clinical Design Technologies Limited
- Date of Incorporation 28 Aug, 2014
- Jurisdiction NEWTON ABBOT, DEVON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.03 M (USD)
in 9 rounds
-
Latest Funding Round
$29.85 K (USD), Seed
Oct 09, 2023
- Investors
-
Employee Count
5
as on Jul 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clinical Design
Clinical Design offers a comprehensive portfolio of products and services, including UTS, UTS-10 Cap, and UTS Digital Analyser. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Digital device for fast and accurate urinalysis at point of care
Single-use caps with reagent pads for 10 diagnostic parameters
Analyzer providing precise urine test results for healthcare use
Unlock access to complete
Unlock access to complete
Funding Insights of Clinical Design
Clinical Design has successfully raised a total of $7.03M across 9 strategic funding rounds. The most recent funding activity was a Seed round of $29.85 thousand completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Seed — $29,845
-
First Round
First Round
(01 Jun 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Seed - Clinical Design | Valuation |
investors |
|
| Jul, 2023 | Amount | Seed - Clinical Design | Valuation |
investors |
|
| Apr, 2022 | Amount | Seed - Clinical Design | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Clinical Design
Clinical Design has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Cornwall & Isles of Scilly Investment Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding is provided to SMEs in Cornwall and Isles of Scilly.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Clinical Design
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Clinical Design
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Clinical Design Comparisons
Competitors of Clinical Design
Clinical Design operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bright Uro, DNC Biotechnology, Stream DX, COBIO Smart Healthcare Technology and Clariflow, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic devices for lower urinary tract diseases are developed.
|
|
| domain | founded_year | HQ Location |
In vitro diagnostic devices for urine infection detection are developed.
|
|
| domain | founded_year | HQ Location |
Uro-flow meters for LUTS diagnosis and patient care are provided.
|
|
| domain | founded_year | HQ Location |
High-throughput clinical analyzers, microscopes, and glucometers are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Provides DIY test kits for benign prostatic hyperplasia (BPH).
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Clinical Design
When was Clinical Design founded?
Clinical Design was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is Clinical Design located?
Clinical Design is headquartered in Truro, United Kingdom. It is registered at Truro, Cornwall, United Kingdom.
Who is the current CEO of Clinical Design?
Oliver Blackwell is the current CEO of Clinical Design. They have also founded this company.
Is Clinical Design a funded company?
Clinical Design is a funded company, having raised a total of $7.03M across 9 funding rounds to date. The company's 1st funding round was a Seed of $1.13M, raised on Jun 01, 2016.
How many employees does Clinical Design have?
As of Jul 31, 2021, the latest employee count at Clinical Design is 5.
What does Clinical Design do?
Developer of a urine diagnostic medical device. The company has developed a patented device called UTS-10 Cap which content the reagent pad to test ten parameters: leukocytes, nitrite, urobilinogen, protein, pH, blood, specific gravity, ketone, bilirubin, and glucose. The result is showed in the UTS digital analyzer which is connected to the UTS-10 Cap.
Who are the top competitors of Clinical Design?
Clinical Design's top competitors include Bright Uro, DNC Biotechnology and Stream DX.
What products or services does Clinical Design offer?
Clinical Design offers UTS, UTS-10 Cap, and UTS Digital Analyser.
Who are Clinical Design's investors?
Clinical Design has 1 investor. Key investors include Cornwall & Isles of Scilly Investment Fund.
What is Clinical Design's valuation?
The valuation of Clinical Design is $13.82M as of Jul 2021.